In this issue:
Risk-based PSA monitoring after radical prostatectomy
Niraparib + abiraterone acetate + prednisone for HRR-deficient mCSPC
Sextant- vs extended-systematic biopsy for prostate cancer diagnosis
PSMA PET-guided intensification of SRT after radical prostatectomy
Active monitoring, surgery, and RT for cribriform-positive/negative prostate cancer
177Lu-PSMA neoadjuvant to stereotactic ablative RT for oligorecurrent prostate cancer
Metformin active surveillance trial in low-risk prostate cancer
Capivasertib + abiraterone in PTEN-deficient mHSPC
Online treatment decision aid for low-risk prostate cancer eligible for active surveillance
Target trial emulation of early docetaxel and enzalutamide for mHSPC
Please login below to download this issue (PDF)